Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women (H4HW)

28 maart 2022 bijgewerkt door: Susana Cristina Araújo Póvoas, University Institute of Maia

Effects of a Short- and Long-term Team Handball-based Exercise Programme on Physical Fitness and Health Status of Inactive Postmenopausal Women

This study aimed at determining the short- (16 weeks) and long-term (36 weeks) health and physical fitness effects and adherence of recreational team handball training for postmenopausal women without previous experience with the sport.

The investigators hypothesized that short-term recreational team handball training would result in positive health and physical fitness adaptations and that the health and physical fitness improvements achieved after the first 16 weeks would be maintained or further improved at the long-term. Moreover, the investigators also hypothesized that the adherence to this exercise mode would be maintained throughout the 36 weeks (long-term) compared to the first 16 weeks (short-term).

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Studietype

Ingrijpend

Inschrijving (Werkelijk)

80

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Portugal
    • Porto
      • Maia, Porto, Portugal, 4476-690
        • University of Maia

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Vrouw

Beschrijving

Inclusion Criteria:

  • Inactive postmenopausal women aged +55 years or younger if with menopause for at least 3 years

Exclusion Criteria:

  • Any medical contraindications to perform moderate-to-vigorous physical activity

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Team handball group
The team handball group participants were encouraged to performed at least two out of three weekly supervised team handball training sessions of 60 min each, for 36 weeks.
Ander: Recreational team handball
Two to three weekly sessions of recreational team handball training for 36 weeks. Each 60-min session started with a standardised warm-up (including running, coordination, strength, flexibility, and balance exercises) followed by three 15-min periods of recreational team handball matches, interspersed by 2-min breaks, played as small-sided games (4v4, 5v5 or 6v6). The training sessions were performed on an indoor team handball court (40x20 m) adjusted to result in 34-36 m2 per player. During the matches, the participants rotated positions every 3 min in a random order, including the goalkeeper and no exclusions or substitutions were applied.
Geen tussenkomst: Control group
The control group participants were instructed to keep their regular daily physical activity for 36 weeks.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Between group differences in peak oxygen uptake at week 16
Tijdsspanne: Week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16
Between group differences in peak oxygen uptake at week 36
Tijdsspanne: Week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 36
Changes from baseline in peak oxygen uptake at week 16
Tijdsspanne: Baseline and week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 16
Changes from baseline in peak oxygen uptake at week 36
Tijdsspanne: Baseline and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 36
Changes from week 16 in peak oxygen uptake at week 36
Tijdsspanne: Week 16 and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16 and week 36

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Between group differences in resting heart rate at week 16
Tijdsspanne: Week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16
Between group differences in resting heart rate at week 36
Tijdsspanne: Week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 36
Changes from baseline in resting heart rate at week 16
Tijdsspanne: Baseline and week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 16
Changes from baseline in resting heart rate at week 36
Tijdsspanne: Baseline and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 36
Changes from week 16 in resting heart rate at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16 and week 36
Between group differences in body mass at week 16
Tijdsspanne: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in body mass at week 36
Tijdsspanne: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in body mass at week 16
Tijdsspanne: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in body mass at week 36
Tijdsspanne: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in body mass at week 36
Tijdsspanne: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in fat mass at week 16
Tijdsspanne: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in fat mass at week 36
Tijdsspanne: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in fat mass at week 16
Tijdsspanne: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in fat mass at week 36
Tijdsspanne: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in fat mass at week 36
Tijdsspanne: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lean mass at week 16
Tijdsspanne: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in lean mass at week 36
Tijdsspanne: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in lean mass at week 16
Tijdsspanne: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in lean mass at week 36
Tijdsspanne: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in lean mass at week 36
Tijdsspanne: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral density at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral density at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral density at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral density at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral density at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral density at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral density at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral density at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral density at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral density at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral density at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral density at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral density at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral density at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral density at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral content at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral content at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral content at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral content at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral content at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral content at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral content at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral content at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral content at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral content at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral content at week 16
Tijdsspanne: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral content at week 36
Tijdsspanne: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral content at week 16
Tijdsspanne: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral content at week 36
Tijdsspanne: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral content at week 36
Tijdsspanne: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in osteocalcin at week 16
Tijdsspanne: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in osteocalcin at week 36
Tijdsspanne: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in osteocalcin at week 16
Tijdsspanne: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in osteocalcin at week 36
Tijdsspanne: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in osteocalcin at week 36
Tijdsspanne: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in procollagen type-1 amino-terminal propeptide at week 16
Tijdsspanne: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in procollagen type-1 amino-terminal propeptide at week 36
Tijdsspanne: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 16
Tijdsspanne: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 36
Tijdsspanne: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in procollagen type-1 amino-terminal propeptide at week 36
Tijdsspanne: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 16
Tijdsspanne: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 36
Tijdsspanne: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 16
Tijdsspanne: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 36
Tijdsspanne: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in carboxy-terminal type-1 collagen crosslinks at week 36
Tijdsspanne: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in sclerostin at week 16
Tijdsspanne: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in sclerostin at week 36
Tijdsspanne: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in sclerostin at week 16
Tijdsspanne: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in sclerostin at week 36
Tijdsspanne: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in sclerostin at week 36
Tijdsspanne: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in isometric knee extension peak torque at week 16
Tijdsspanne: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension peak torque at week 36
Tijdsspanne: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension peak torque at week 16
Tijdsspanne: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension peak torque at week 36
Tijdsspanne: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension peak torque at week 36
Tijdsspanne: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in isometric knee extension rate of force development at week 16
Tijdsspanne: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension rate of force development at week 36
Tijdsspanne: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension rate of force development at week 16
Tijdsspanne: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension rate of force development at week 36
Tijdsspanne: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension rate of force development at week 36
Tijdsspanne: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in upper body strength at week 16
Tijdsspanne: Week 16
Determined by a handgrip dynamometer.
Week 16
Between group differences in upper body strength at week 36
Tijdsspanne: Week 36
Determined by a handgrip dynamometer.
Week 36
Changes from baseline in upper body strength at week 16
Tijdsspanne: Baseline and week 16
Determined by a handgrip dynamometer.
Baseline and week 16
Changes from baseline in upper body strength at week 36
Tijdsspanne: Baseline and week 36
Determined by a handgrip dynamometer.
Baseline and week 36
Changes from week 16 in upper body strength at week 36
Tijdsspanne: Week 16 and week 36
Determined by a handgrip dynamometer.
Week 16 and week 36
Between group differences in postural balance at week 16
Tijdsspanne: Week 16
Determined by the number of falls in a single-legged flamingo balance test.
Week 16
Between group differences in postural balance at week 36
Tijdsspanne: Week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 36
Changes from baseline in postural balance at week 16
Tijdsspanne: Baseline and week 16
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 16
Changes from baseline in postural balance at week 36
Tijdsspanne: Baseline and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 36
Changes from week 16 in postural balance at week 36
Tijdsspanne: Week 16 and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 16 and week 36
Between group differences in aerobic performance at week 16
Tijdsspanne: Week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16
Between group differences in aerobic performance at week 36
Tijdsspanne: Week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 36
Changes from baseline in aerobic performance at week 16
Tijdsspanne: Baseline and week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 16
Changes from baseline in aerobic performance at week 36
Tijdsspanne: Baseline and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 36
Changes from week 16 in aerobic performance at week 36
Tijdsspanne: Week 16 and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16 and week 36
Between group differences in total cholesterol at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in total cholesterol at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in total cholesterol at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in total cholesterol at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in total cholesterol at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in high-density lipoprotein cholesterol at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in high-density lipoprotein cholesterol at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in high-density lipoprotein cholesterol at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in high-density lipoprotein cholesterol at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in high-density lipoprotein cholesterol at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in low-density lipoprotein cholesterol at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in low-density lipoprotein cholesterol at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in low-density lipoprotein cholesterol at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in low-density lipoprotein cholesterol at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in low-density lipoprotein cholesterol at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in triglycerides at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in triglycerides at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in triglycerides at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in triglycerides at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in triglycerides at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting glucose at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting glucose at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in fasting glucose at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in fasting glucose at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in fasting glucose at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting insulin at week 16
Tijdsspanne: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting insulin at week 36
Tijdsspanne: Week 36
Determined by an automated analyser.
Week 36
Change from baseline in fasting insulin at week 16
Tijdsspanne: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Change from baseline in fasting insulin at week 36
Tijdsspanne: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Change from week 16 in fasting insulin at week 36
Tijdsspanne: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in glucose tolerance at week 16
Tijdsspanne: Week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16
Between group differences in glucose tolerance at week 36
Tijdsspanne: Week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 36
Changes from baseline in glucose tolerance at week 16
Tijdsspanne: Baseline and week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 16
Changes from baseline in glucose tolerance at week 36
Tijdsspanne: Baseline and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 36
Changes from week 16 in glucose tolerance at week 36
Tijdsspanne: Week 16 and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16 and week 36

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

University Institute of Maia

Medewerkers

University of Southern Denmark
Universidade do Porto
Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto
Research Center in Sports Sciences, Health Sciences and Human Development (CIDESD)
Centre of Research, Education, Innovation and Intervention in Sport, University of Porto
Porto Sports Medicine Center (IPDJ, IP)
Gaia City Hall
Portuguese Handball Federation
São João University Hospital Centre
EPIUnit, Public Health Institute, University of Porto
Laboratory of Metabolism and Exercise (LaMetEx), CIAFEL, Faculty of Sport, University of Porto
European Handball Federation

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

2 januari 2016

Primaire voltooiing (Werkelijk)

1 maart 2018

Studie voltooiing (Werkelijk)

1 maart 2018

Studieregistratiedata

Eerst ingediend

14 maart 2022

Eerst ingediend dat voldeed aan de QC-criteria

14 maart 2022

Eerst geplaatst (Werkelijk)

23 maart 2022

Updates van studierecords

Laatste update geplaatst (Werkelijk)

6 april 2022

Laatste update ingediend die voldeed aan QC-criteria

28 maart 2022

Laatst geverifieerd

1 maart 2022

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • CEFADE202019

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Recreational team handball

Zoek naar vergelijkbare onderzoeken

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

CROs by country

CROs in Colombia

Voorwaarden

Zeldzame ziekten

Geneesmiddelinterventies

Voedingssupplementen

Sponsor / medewerkers

Locaties

3
Abonneren